Ingrid Pabinger Selected Research

Lupus Coagulation Inhibitor (Lupus Anticoagulant)

1/2020	Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis.
12/2019	High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.
2/2019	Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
10/2017	Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.
5/2015	Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
10/2011	Acquired immune-mediated thrombophilia in lymphoproliferative disorders.
1/2008	Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant.
1/2007	The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
5/2006	Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.
3/2005	The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Pabinger Research Topics

Disease

58	Neoplasms (Cancer) 04/2022 - 06/2006
50	Thrombosis (Thrombus) 01/2022 - 09/2002
49	Venous Thromboembolism 04/2022 - 09/2002
43	Hemorrhage 08/2022 - 04/2002
26	Hemophilia A (Haemophilia) 02/2022 - 11/2005
18	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2021 - 08/2006
15	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 09/2002
12	Thromboembolism 08/2022 - 03/2005
10	Atrial Fibrillation 08/2022 - 12/2014
9	Thrombophilia 12/2021 - 09/2002
9	Pulmonary Embolism 02/2018 - 09/2002
8	Inflammation (Inflammations) 01/2021 - 03/2005
7	Stroke (Strokes) 12/2021 - 01/2007
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2013
4	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2008
4	Brain Neoplasms (Brain Tumor) 05/2021 - 02/2013
4	Pre-Eclampsia (Preeclampsia) 12/2019 - 09/2006
4	Pregnancy Complications 12/2019 - 06/2008
4	Habitual Abortion (Recurrent Miscarriage) 01/2009 - 12/2003
4	Hyperhomocysteinemia 01/2009 - 07/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 08/2022 - 10/2017
3	Lung Neoplasms (Lung Cancer) 05/2021 - 01/2018
3	Disseminated Intravascular Coagulation 03/2021 - 03/2014
3	Disease Progression 01/2021 - 05/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
3	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 01/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2015
3	Glioma (Gliomas) 01/2020 - 12/2014
3	Protein S Deficiency (Deficiency, Protein S) 01/2013 - 01/2008
3	Congenital Abnormalities (Deformity) 12/2003 - 09/2002
3	Antithrombin III Deficiency 12/2003 - 09/2002
2	Infections 01/2022 - 12/2010
2	Portal Hypertension 01/2022 - 08/2008
2	Sepsis (Septicemia) 09/2021 - 04/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2020
2	Wounds and Injuries (Trauma) 01/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 08/2022 - 03/2009
27	AnticoagulantsIBA 01/2022 - 04/2002
23	Factor VIII (Coagulation Factor VIII)IBA 04/2022 - 03/2005
19	fibrin fragment D (D-dimer)IBA 01/2022 - 10/2007
17	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021 - 05/2004
16	Thromboplastin (Tissue Factor)IBA 01/2022 - 04/2010
16	P-SelectinIBA 01/2019 - 10/2006
12	Thrombin FDA Link 01/2022 - 05/2011
11	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020 - 03/2005
10	AntibodiesIBA 01/2022 - 11/2003
10	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 09/2002
10	Antiphospholipid AntibodiesIBA 12/2019 - 09/2002
10	Prothrombin (Factor II)IBA 04/2012 - 09/2002
8	AntithrombinsIBA 12/2019 - 09/2002
8	Inosine Triphosphate (ITP)IBA 01/2019 - 12/2010
8	SelectinsIBA 01/2019 - 07/2007
7	Hemostatics (Antihemorrhagics)IBA 11/2021 - 08/2008
6	von Willebrand FactorIBA 01/2022 - 07/2019
6	Vitamin K FDA Link 12/2021 - 06/2008
6	romiplostim FDA Link 01/2019 - 11/2010
6	factor V LeidenIBA 01/2013 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2007
5	EnzymesIBA 10/2021 - 12/2019
5	C-Reactive ProteinIBA 01/2020 - 03/2005
4	ABO Blood-Group SystemIBA 04/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2006
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2007
4	Immunoglobulin M (IgM)IBA 11/2021 - 01/2007
4	Protein CIBA 09/2021 - 09/2002
4	Blood Coagulation Factors (Coagulation Factor)IBA 07/2017 - 04/2002
4	eltrombopag FDA Link 04/2013 - 02/2009
3	RivaroxabanIBA 01/2022 - 09/2015
3	Platelet Factor 4IBA 10/2021 - 01/2016
3	Histones (Histone)IBA 01/2021 - 01/2019
3	Fibrinogen (Factor I)FDA Link 01/2021 - 03/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 06/2008
3	Blood Group Antigens (Blood Groups)IBA 10/2020 - 03/2005
3	Azathioprine (Imuran)FDA LinkGeneric 09/2020 - 05/2006
3	AlbuminsIBA 02/2016 - 03/2009
3	Factor V (Coagulation Factor V)IBA 08/2003 - 09/2002
2	Growth Differentiation Factor 15IBA 01/2022 - 01/2021
2	apixabanIBA 01/2022 - 11/2020
2	Cell-Free Nucleic AcidsIBA 12/2021 - 01/2019
2	ThrombomodulinIBA 11/2021 - 09/2021
2	ChAdOx1 nCoV-19IBA 10/2021 - 01/2021
2	VaccinesIBA 10/2021 - 01/2021
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2021 - 01/2021
2	FibrinIBA 05/2021 - 02/2014
2	ProteomeIBA 05/2021 - 01/2020
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 05/2021 - 05/2017
2	Plasminogen Activator Inhibitor 1IBA 05/2021 - 01/2021
2	BAY 94-9027IBA 05/2021 - 07/2020
2	Dacarbazine (DIC)FDA LinkGeneric 03/2021 - 01/2017
2	AntigensIBA 01/2021 - 07/2019
2	CytokinesIBA 01/2021 - 12/2019
2	A-factor (Streptomyces)IBA 01/2021 - 05/2017
2	Warfarin (Coumadin)FDA LinkGeneric 11/2020 - 08/2008
2	factor VIII-Fc fusion proteinIBA 05/2020 - 01/2014
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 06/2008

Therapy/Procedure

27	Therapeutics 01/2022 - 04/2002
11	Drug Therapy (Chemotherapy) 11/2021 - 09/2009
6	Splenectomy 10/2011 - 05/2006
5	Renal Dialysis (Hemodialysis) 08/2022 - 01/2017
3	Blood Transfusion (Blood Transfusions) 05/2017 - 11/2010